MedTrace Logo

Impact of Vitamin D Repletion in Hemodialysis Patients

NCT01175798 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 116

Last updated 2014-09-22

Study results available
· View outcomes & findings →

Summary

Dialysis patients often suffer from defects in their immune system (that part of the body which fights infection). Evidence suggests that Vitamin D deficiency may have a negative effect on immunity, and many dialysis patients are deficient in Vitamin D. We believe that by giving Vitamin D to dialysis patients who are deficient, we may help improve their immune system. This study will test that idea.

Conditions

  • Vitamin D Deficiency
  • End-stage Renal Disease

Interventions

DRUG

Cholecalciferol

50,000 IU PO weekly x 6 weeks

Sponsors & Collaborators

  • National Kidney Foundation, United States

    collaborator OTHER

  • American Heart Association

    collaborator OTHER

  • Mehrotra, Anita, M.D.

    lead INDIV

Principal Investigators

  • Anita Mehrotra, MD · Icahn School of Medicine at Mount Sinai

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2013-08-31
Completion
2013-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01175798 on ClinicalTrials.gov